CD28 and cancer: The findings demonstrated that the PD1/CD28 CSR could enhance the phosphorylation of crucial signaling molecules, such as ERK and Akt, thereby profoundly impacting CTL stimulation, proliferation, and cytokine secretion—fundamental processes for an effective immune response against cancer cells [67].